Paper Review Records
All Paper Review Records
20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
182
days
Generational gains in cognitive capacity and dementia incidence rates in Western countries
Authors
Anders M. Fjell; Edvard O. S. Grødem; Gabriela Lunansky; Didac Vidal-Piñeiro; Ole Rogeberg; Kristine B. WalhovdShow moreShow less
Affiliations
1. Center for Lifespan Changes in Brain and Cognition, University of Oslo, Oslo, Norway; 2. Computational Radiology and Artificial Intelligence, Department of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway; 3. Department of Epidemiology and Data Science, Amsterdam University Medical Centers (VUmc), Amsterdam, Netherlands; 4. Ragnar Frisch Centre for Economic Research, Oslo, NorwayShow moreShow less
232
days
An open agentic AI co-scientist for clinical and biomedical discovery
Authors
Kaleigh F. Roberts; Zachary B. Abrams; Luca Cappelletti; Mahdi Moqri; Nicholas Heugel; J. Harry Caufield; Mathieu Bourdenx; Yan Li; Jineta Banerjee; Luca Foschini; Diego Galeano; Nomi L. Harris; Melody Li; Kejun Ying; Justin A. Melendez; Nicolas R. Barthélemy; James G. Bollinger; Yingxin He; Vitaliy Ovod; Tammie L. S. Benzinger; Shaney Flores; Brian A. Gordon; Taylor Pedersen; Jinsheng Yu; Brendan P. Lucey; Erik S. Musiek; Sarah A. Naylor; Adegoke A. Ojewole; Mukta Phatak; Donald L. Elbert; Sarah Biber; Eric C. Landsness; Christopher J. Mungall; Randall J. Bateman; Justin T. ReeseShow moreShow less
Affiliations
1. Department of Pathology & Immunology, Washington University in St. Louis, St. Louis, USA; 2. Tracy Family SILQ Center, Washington University in St. Louis, St. Louis, USA; 3. Consortium for Biomedical Research & AI in Neurodegeneration (C-BRAIN), St. Louis, USA; 4. Institute for Informatics, Data Science, and Biostatistics, Washington University in St. Louis, St. Louis, USA; 5. Department of Biology, University of Fribourg, Fribourg, Switzerland; 6. Department of Medicine, Harvard Medical School, Boston, USA; 7. Department of Neurology, Washington University in St. Louis, St. Louis, USA; 8. Division of Environmental Genomics and Systems Biology, Lawrence Berkeley National Laboratory, Berkeley, USA; 9. UK Dementia Research Institute at University College London, London, UK; 10. Sage Bionetworks, Seattle, USA; 11. Electronics and Mechatronics Department, Facultad de Ingenieria, Universidad Nacional de Asuncion, Luque, Paraguay; 12. Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, USA; 13. Tesabio.ai, Boston, USA; 14. Department of Neurology and Neurological Sciences, Stanford University, Stanford, USA; 15. Institute for Protein Design, University of Washington, Seattle, USA; 16. Department of Radiology, Washington University in St. Louis, St. Louis, USA; 17. Department of Psychological and Brain Sciences, Washington University in St. Louis, St. Louis, USA; 18. Department of Genetics and McDonnell Genome Institute, Washington University in St. Louis, St. Louis, USA; 19. Department of Neurology, University of Minnesota Medical School, Minneapolis, USA; 20. The 10, 000 Brains Project, Oakland, USA; 21. Department of Neurology, University of Washington, Seattle, USAShow moreShow less
394
days
Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer
Authors
Marina C. Garassino; Myung-Ju Ahn; Markus Schick; Ansh Kapil; Luis Paz-Ares; Aaron Lisberg; Melissa L. Johnson; Maurice Pérol; Toshio Shimizu; Rebecca Heist; Alexander Spira; Isamu Okamoto; Nicolas Girard; Robin Cornelissen; Elvire Pons-Tostivint; Min Hee Hong; Ricardo Zwirtes; Rachel Chiaverelli; Marlon Rebelatto; Matthew Sung; Chuyu Deng; James Harper; Danielle Carroll; Hadassah Sade; Jacob SandsShow moreShow less
Affiliations
1. The University of Chicago, Chicago, USA; 2. Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; 3. Computational Pathology, AstraZeneca, Munich, Germany; 4. Universidad Complutense and CiberOnc, Hospital Universitario 12 de Octubre, Madrid, Spain; 5. Jonsson Comprehensive Cancer Center at UCLA, Los Angeles, USA; 6. Sarah Cannon Research Institute, Nashville, USA; 7. Léon-Bérard Cancer Center, Lyon, France; 8. National Cancer Centre Hospital, Kansai Medical University Hospital, Hirakata, Japan; 9. Massachusetts General Hospital, Boston, USA; 10. Virginia Cancer Specialists (VCS) Research Institute, Fairfax, USA; 11. Kyushu University Hospital, Fukuoka, Japan; 12. Institut Curie, Paris, France; 13. Erasmus MC Cancer Institute, Rotterdam, the Netherlands; 14. University Hospital of Nantes, Nantes, France; 15. Yonsei Cancer Center, Severance Hospital, Seoul, Republic of Korea; 16. Clinical Development, Daiichi Sankyo, Basking Ridge, USA; 17. Pfizer, Inc., New York, USA; 18. Translational Medicine, Daiichi Sankyo, Basking Ridge, USA; 19. GlaxoSmithKline Oncology Translational Medicine, Philadelphia, USA; 20. Translational Pathology, AstraZeneca, Gaithersburg, USA; 21. Oncology Targeted Discovery, AstraZeneca, Waltham, USA; 22. Biometrics, Oncology R&D, AstraZeneca, Boston, USA; 23. Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK; 24. GlaxoSmithKline Oncology Translational Medicine, Stevenage, UK; 25. Dana-Farber Cancer Institute, Boston, USAShow moreShow less
400
days
Blood-based RNA biomarker for the early detection of ovarian cancer
Authors
Jochen Wilhelm; Amit Kumar; Hitesh Vasiyani; Narsimha Mamidi; Zhaoyu Sun; Aenya Gogna; Praveen Bhoopathi; Keshav C. Gogna; Chelsea Salyer; Amy Lu; Kranthi Kumar Chougoni; Ava N. Gardner; Andrew S. Poklepovic; Masaki Nagane; Kumari S. Shree; Emad A. Rakha; Karuppaiyah Selvendiran; George L. Maxwell; Jamie N. Bakkum-Gamez; Shariska Petersen Harrington; Elnaz Abbasi Farid; Nadia Traficante; David Bowtell; Christopher D. Collier; Rebecca Z. Drexler; Christine Kramer; Mary M. Mullen; Alexandar Tzankov; Kirsten D. Mertz; Jun Watanabe; Shimpei Nagai; Tatsuyuki Chiyoda; Wataru Yamagami; Kenta Masuda; Elena Garre; Göran Landberg; David L. Kolin; Calla O’Connor; Sarah A. Ackroyd; Bodour Salhia; Paola A. Gehrig; Aanya Singh; Tytus Bernas; Anusha Challa; Sriram Sriperumbuduri; Nolan A. Wages; Jordan Lewis; Lien Hoang; Janice S. Kwon; Jasmin D. Haslbauer; Mark P. Kühnel; T. Rinda Soong; Sarah Taylor; Carlos Zuazo; Tiffany Beck; Michael J. Demeure; Marc R. Radke; Sourat Darabi; Denise Connolly; Barbara S. Norquist; Nozomi Yachida; Kazuaki Suda; Kosuke Yoshihara; Tu-Yung Chang; Patrick Martin; Kyoung Jae Won; Tian-Li Wang; Ie-Ming Shih; Thomas Russell Pisanic; Tanvir K. Dhaliwal; Vandanaa Jayaprakash; Bukola Adeshina; Seungpyo Hong; Ana Blanca; David R. Braxton; Cesar M. Castro; Elizabeth M. Swisher; Allan Tsung; Ernst Lengyel; Susan Domchek; William L. Redmond; Yonglun Luo; Ole Mogensen; Robert A. Winn; Bo R. Rueda; Ronny Drapkin; Andrew K. Godwin; Ronald J. Buckanovich; Kenneth P. Nephew; Rafael J. Luque; Antonio Lopez-Beltran; Robert L. Coleman; Daniel Von Hoff; David Sidransky; Maximilian Ackermann; Danny Jonigk; Steven R. Grossman; Ranjit Manchanda; Rajan Gogna; Esha MadanShow moreShow less
Affiliations
1. Institute for Lung Health (ILH), Universities Giessen & Marburg Lung Center (UGMLC), German Center for Lung Research (DZL), Justus-Liebig-University Giessen, Giessen, Germany; 2. Cell Competition in Tumour Microenvironment Laboratory, Hoag Family Cancer Institute, Newport Beach, USA; 3. Wisconsin Center for NanoBioSystems, School of Pharmacy, University of Wisconsin, Madison, USA; 4. Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, USA; 5. Sage Hill School, Newport Coast, USA; 6. Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, USA; 7. Department of Precision Medicine, Hoag Family Cancer Institute, Newport Beach, USA; 8. Department of Biochemistry, School of Veterinary Medicine, Azabu University, Kanagawa, Japan; 9. Department of Histopathology, Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Nottingham, UK; 10. Nottingham Breast Cancer Research Centre, School of Medicine, Academic Unit for Translational Medical Sciences, University of Nottingham, Nottingham, UK; 11. Division of Gynecologic Oncology, Department of Obstetrics/Gynecology, Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, USA; 12. Inova Women’s Service Line and the Inova Schar Cancer Institute, Falls Church, USA; 13. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, USA; 14. Mayo Clinic Hospital, Methodist Campus, Rochester, USA; 15. Indiana University School of Medicine-Bloomington, Indiana University, Bloomington, USA; 16. Indiana University Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, USA; 17. Peter MacCallum Cancer Centre, Melbourne, Australia; 18. Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia; 19. Department of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, USA; 20. Division of Endocrinology, Metabolism and Lipid Research, John T. Milliken Department of Medicine, Washington University, St. Louis, USA; 21. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Siteman Cancer Center, Washington University School of Medicine, St. Louis, USA; 22. Institute of Medical Genetics and Pathology, University Hospital Basel and University of Basel, Basel, Switzerland; 23. Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan; 24. Sahlgrenska Center for Cancer Research, Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden; 25. Department of Obstetrics, Gynecology, and Reproductive Biology, Harvard Medical School, Boston, USA; 26. Department of Obstetrics and Gynecology, University of Chicago, Chicago, USA; 27. Department of Translational Genomics, Keck School of Medicine, University of Southern California, Los Angeles, USA; 28. Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, USA; 29. Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada; 30. Division Gynecology Oncology, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada; 31. Institute of Pathology, RWTH Aachen Medical University, Aachen, Germany; 32. Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover Medical School, Hanover, Germany; 33. Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, USA; 34. Department of Obstetrics and Gynecology, University of Pittsburgh School of Medicine, Pittsburgh, USA; 35. Department of Obstetrics and Gynecology, University of Washington, Seattle, USA; 36. Fox Chase Cancer Center, Biosample Repository Facility, Philadelphia, USA; 37. Department Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan; 38. Department of Gynecology & Obstetrics, Johns Hopkins University School of Medicine, Baltimore, USA; 39. Department of Computational Biomedicine, Cedars-Sinai Medical Center, Los Angeles, USA; 40. Departments of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, USA; 41. The Johns Hopkins Institute for Nanobiotechnology, Johns Hopkins School of Medicine, Baltimore, USA; 42. Joan C. Edwards School of Medicine, Marshall University, Huntington, USA; 43. Pharmaceutical Sciences Division, School of Pharmacy, University of Wisconsin, Madison, USA; 44. Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin—Madison, Madison, USA; 45. Department of Morphological Sciences, Cordoba University Medical School, Cordoba, Spain; 46. Center for Systems Biology, Massachusetts General Hospital Research Institute, Boston, USA; 47. Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, USA; 48. Department of Surgery, Division of Surgical Oncology, University of Virginia, Charlottesville, USA; 49. Penn Ovarian Cancer Research Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA; 50. Department of Biomedicine, Aarhus University, Aarhus, Denmark; 51. Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark; 52. Fox Chase Cancer Center, Temple Health, Philadelphia, USA; 53. Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, USA; 54. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, USA; 55. Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, USA; 56. Kansas Institute for Precision Medicine, University of Kansas Medical Center, Kansas City, USA; 57. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, UPMC Hillman Cancer Center and the Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, USA; 58. Department of Medicine, University of Pittsburgh, Pittsburgh, USA; 59. Pathological Anatomy Unit, University Hospital of Jaén, Jaén, Spain; 60. Department of Pathology, Cordoba University Medical School, Cordoba, Spain; 61. Centro Clínico Champalimaud, Lisboa, Portugal; 62. Department of Surgery, Cordoba University Medical School, Cordoba, Spain; 63. Gynecologic Oncology, Texas Oncology, The Woodlands, USA; 64. The Translational Genomics Research Institute, Phoenix, USA; 65. Department of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, USA; 66. Institute of Functional and Clinical Anatomy, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany; 67. Institute of Pathology and Molecular Pathology, Helios University Clinic Wuppertal, University of Witten/Herdecke, Wuppertal, Germany; 68. Department of Gynaecological Oncology, Barts Health NHS Trust, Royal London Hospital, London, UK; 69. Department of Health Services Research, Faculty of Public Health & Policy, London School of Hygiene & Tropical Medicine, London, UK; 70. Centre for Cancer Screening, Prevention & Early Diagnosis (CCSPED), Wolfson Institute of Population Health, Queen Mary University of London, London, UKShow moreShow less
72
days
Resistance exercise to attenuate lean mass loss during tirzepatide therapy for obesity: a randomized controlled trial
Authors
Daniel J. Green; Andrew Haynes; Destiny R. Underwood; Evangeline R. Winterton; Abbey A. Green; Robin M. Daly; Elena S. George; Leanne Lester; Louise H. Naylor; Graham S. Hillis; P. Gerry Fegan; Bu B. YeapShow moreShow less
Affiliations
1. School of Human Sciences (Exercise and Sport Science), University of Western Australia, Perth, Australia; 2. The Healthspan Institute, University of Western Australia, Perth, Australia; 3. Institute of Sport, Manchester Metropolitan University, Manchester, UK; 4. Deakin Institute for Physical Activity and Nutrition, School of Exercise and Nutrition Sciences, Deakin University, Geelong, Australia; 5. Centre for Social Impact, University of Western Australia, Perth, Australia; 6. Medical School, University of Western Australia, Perth, Australia; 7. Department of Cardiology, Royal Perth Hospital, Perth, Australia; 8. Medical School, Curtin University, Perth, Australia; 9. Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Perth, AustraliaShow moreShow less
27
days
Neoadjuvant durvalumab plus chemotherapy in resectable or borderline resectable non-small-cell lung cancer: the phase 2 MDT-BRIDGE trial
Authors
Martin Reck; Ernest Nadal; Carl M. Gay; Nicolas Girard; Andrea Riccardo Filippi; Linda W. Martin; Cordula Petersen; David A. Cairns; Margarita Majem; Andrea Ardizzoni; Rosa Alvarez Alvarez; Andrew Robinson; Benoit Roch; Arnaud Boyer; Ilaria Attili; Maximilian Diehn; David Kurtz; Ugochinyere A. Emeribe; Ignacio Diaz Perez; Matteo Giaj Levra; Davina Gale; Zhou Zhu; Nefeli Georgoulia; Jonathan SpicerShow moreShow less
Affiliations
1. Lung Clinic Großhansdorf, Airway Research Center North, German Center for Lung Research, Großhansdorf, Germany; 2. Department of Medical Oncology, Institut Català d’Oncologia (ICO), IDIBELL, Bellvitge Healthcare Campus, L’Hospitalet de Llobregat, Barcelona, Spain; 3. Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA; 4. Institut du Thorax Curie-Montsouris, Institut Curie/UVSQ, Paris, France; 5. Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; 6. Department of Oncology, University of Milan, Milan, Italy; 7. Division of Thoracic Surgery, Department of Surgery, University of Virginia, Charlottesville, USA; 8. Department of Radiotherapy and Radiation Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; 9. Leeds Cancer Research UK Clinical Trials Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, UK; 10. Department of Medical Oncology, Institut de Recerca Sant Pau (IR Sant Pau), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; 11. Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 12. Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy; 13. Medical Oncology Department, Hospital Universitario Gregorio Marañón, Madrid, Spain; 14. Cancer Centre of Southeastern Ontario at Kingston General Hospital, Kingston, Canada; 15. Centre Hospitalier Universitaire de Montpellier, Montpellier, France; 16. Hôpital Saint Joseph, Marseille, France; 17. Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan, Italy; 18. Department of Radiation Oncology, Stanford University, Stanford, USA; 19. Division of Oncology, Department of Medicine, Stanford University, Stanford, USA; 20. AstraZeneca, Wilmington, USA; 21. AstraZeneca, Gaithersburg, USA; 22. AstraZeneca, Cambridge, UK; 23. Department of Thoracic Surgery, McGill University, Montreal, CanadaShow moreShow less
FAQ
How long does NATURE MEDICINE take to review a manuscript?
As of 2026-11-18, CrushSCI has 20 complete review records for NATURE MEDICINE. The fastest paper went from submission to acceptance in 21 days (Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic cancer: the randomized phase 2 AMPLIFY-7P trial, received 2026-09-10, accepted 2026-10-01); the slowest took 423 days. The average is 194.6 days and the median is 195.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
